Severe cold hemagglutinin disease (CHD) successfully treated with rituximab

Standard

Severe cold hemagglutinin disease (CHD) successfully treated with rituximab. / Engelhardt, Monika; Jakob, Andreas; Ruter, Björn; Trepel, Martin; Hirsch, Friedrich; Lübbert, Michael.

in: BLOOD, Jahrgang 100, Nr. 5, 01.09.2002, S. 1922-3.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Engelhardt, M, Jakob, A, Ruter, B, Trepel, M, Hirsch, F & Lübbert, M 2002, 'Severe cold hemagglutinin disease (CHD) successfully treated with rituximab', BLOOD, Jg. 100, Nr. 5, S. 1922-3.

APA

Engelhardt, M., Jakob, A., Ruter, B., Trepel, M., Hirsch, F., & Lübbert, M. (2002). Severe cold hemagglutinin disease (CHD) successfully treated with rituximab. BLOOD, 100(5), 1922-3.

Vancouver

Engelhardt M, Jakob A, Ruter B, Trepel M, Hirsch F, Lübbert M. Severe cold hemagglutinin disease (CHD) successfully treated with rituximab. BLOOD. 2002 Sep 1;100(5):1922-3.

Bibtex

@article{c84c637e002e4438a75c90ec3d065de5,
title = "Severe cold hemagglutinin disease (CHD) successfully treated with rituximab",
keywords = "Anemia, Hemolytic, Autoimmune, Antibodies, Monoclonal, Antibodies, Monoclonal, Murine-Derived, Antineoplastic Agents, Bilirubin, Cell Count, Female, Hemoglobins, Humans, Middle Aged, Reticulocytes, Rituximab, Case Reports, Letter",
author = "Monika Engelhardt and Andreas Jakob and Bj{\"o}rn Ruter and Martin Trepel and Friedrich Hirsch and Michael L{\"u}bbert",
year = "2002",
month = sep,
day = "1",
language = "English",
volume = "100",
pages = "1922--3",
journal = "BLOOD",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "5",

}

RIS

TY - JOUR

T1 - Severe cold hemagglutinin disease (CHD) successfully treated with rituximab

AU - Engelhardt, Monika

AU - Jakob, Andreas

AU - Ruter, Björn

AU - Trepel, Martin

AU - Hirsch, Friedrich

AU - Lübbert, Michael

PY - 2002/9/1

Y1 - 2002/9/1

KW - Anemia, Hemolytic, Autoimmune

KW - Antibodies, Monoclonal

KW - Antibodies, Monoclonal, Murine-Derived

KW - Antineoplastic Agents

KW - Bilirubin

KW - Cell Count

KW - Female

KW - Hemoglobins

KW - Humans

KW - Middle Aged

KW - Reticulocytes

KW - Rituximab

KW - Case Reports

KW - Letter

M3 - SCORING: Journal article

C2 - 12211193

VL - 100

SP - 1922

EP - 1923

JO - BLOOD

JF - BLOOD

SN - 0006-4971

IS - 5

ER -